Helena
Barrasa Gonzalez
Publicacións nas que colabora con Helena Barrasa Gonzalez (11)
2024
2023
-
Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study
Blood Purification, Vol. 52, Núm. 5, pp. 464-473
2022
-
Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
Journal of Intensive Care, Vol. 10, Núm. 1
2021
-
Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function
Pharmaceutics, Vol. 13, Núm. 10
-
Pseudomonas aeruginosa susceptibility in spain: Antimicrobial activity and resistance suppression evaluation by pk/pd analysis
Pharmaceutics, Vol. 13, Núm. 11
-
Quantification of ceftaroline in human plasma using high‐performance liquid chromatography with ultraviolet detection: Application to pharmacokinetic studies
Pharmaceutics, Vol. 13, Núm. 7
2020
-
Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective
International Journal of Infectious Diseases, Vol. 93, pp. 329-338
-
Novel population pharmacokinetic model for linezolid in critically ill patients and evaluation of the adequacy of the current dosing recommendation
Pharmaceutics, Vol. 12, Núm. 1
2019
-
Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment
Journal of Critical Care, Vol. 50, pp. 69-76
2018
-
Augmented Renal Clearance in Critically Ill Patients: A Systematic Review
Clinical Pharmacokinetics, Vol. 57, Núm. 9, pp. 1107-1121
-
Population pharmacokinetics of daptomycin in critically ill patients
International Journal of Antimicrobial Agents, Vol. 52, Núm. 2, pp. 158-165